*Correspondence: Christopher Cardozo [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Why compounded options exist: The significant price difference between FDA-approved branded medications and compounded versions is the primary driver
El medicamento de marca cuesta entre US$ 500 y US$ 815 por paquete, dependiendo de la dosis, antes de descuentos o seguros, segn Novo Nordisk, que tambin vende una versin de liraglutida aprobada para la obesidad, llamada Saxenda
Antibiotics and antidepressants serve as paradigmatic examples of drugs with significant neurological risks manifesting in diverse clinical syndromes and ecological impacts (Table 5)
Semaglutide injection is a once-weekly subcutaneous treatment
Patients 61 to 80 years of age appear to face the highest risk of OSA among all age groups
